CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Pinpoint appother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04579926
NCT04579926N/ACompleted
CompareCT.gov

PINPOINT: Gaming Technology to Engage Adolescent Sickle Cell Patients in Precision Pain Phase II

Klein Buendel, Inc.·interventional·Posted Oct 8, 2020·Updated May 1, 2024

In Brief

A clinical study evaluating Pinpoint app for Sickle Cell Disease and 3 related conditions. Completed, enrolled 24 participants across 2 sites.

Detailed Summary

Sickle cell disease (SCD) is a common genetic disorder characterized by episodes of pain, yet programs to assist SCD adolescents with better identification and communication about pain are lacking. Research shows that interactive gaming technology can enhance adolescents' learning, and can be especially effective in delivering health-related messages and tools to improve self-care. Pinpoint is an interactive gaming app that will be tested in a Phase II project to determine whether the app assists SCD teens with improving their communication and identification skills for pain self-report.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSickle Cell Disease, Sickle Cell Anemia in Children, Sickle Cell Thalassemia, Sickle Cell SC Disease
CountriesUnited States
CollaboratorsNational Institute on Minority Health and Health Disparities (NIMHD), HPC International, Inc.

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 8, 2020
Enrollment StartSep 19, 2018
Primary CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 5.7 years ago

Interventions

Pinpoint appother

Tablet and smartphone app with pain assessment and communication education, and pain assessment tool.